Paclitaxel poliglumex (PPX)/carboplatin vs paclitaxel/carboplatin for the treatment of PS2 patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC): A phase III study.

被引：0

作者：

Langer, CJ

Socinski, MA

Ross, H

O'Byrne, KJ

机构：

[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[2] Univ N Carolina, Chapel Hill, NC USA

[3] Oregon Clin, Portland, OR USA

[4] St James Hosp, Dublin 8, Ireland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1095S / 1095S

页数：1

共 50 条

[21] Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
O'Brien, Mary E. R.
Socinski, Mark A.
Popovich, Alexander Y.
Bondarenko, Igor N.
Tomova, Antoaneta
Bilynskyi, Borys T.
Hotko, Yevhen S.
Ganul, Valentin L.
Kostinsky, Ippolit Y.
Eisenfeld, Amy J.
Sandalic, Larissa
Oldham, Fred B.
Bandstra, Bruce
Sandler, Alan B.
Singer, Jack W.
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 728 - 734
[22] Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During Pregnancy
Azim, Hatem A., Jr.
Scarfone, Giovanna
Peccatori, Fedro A.
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 559 - 560
[23] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
Kanat, Ozkan
Cubukcu, Erdem
Cubukcu, Sinem
Aksoy, Savas
Canhoroz, Mustafa
Karadag, Oya
Alkis, Nihan
Manavolglu, Osman
JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
[24] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
Sadic, Murat
Alavi, Abass
JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
[25] Triplet chemotherapy with paclitaxel, gemcitabine and carboplatin in advanced non-small cell lung cancer
Bunn, PA
Kelly, K
Mikhaeel, N
SEMINARS IN ONCOLOGY, 1999, 26 (06) : 21 - 21
[26] A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): SWOG S0819
Herbst, Roy
Redman, Mary
Kim, Edward S.
Semrad, Thomas J.
Bazhenova, Lyudmila
Masters, Gregory
Oettel, Kurt
Guaglianone, Perry
Reynolds, Christopher
Karnad, Anand
Arnold, Susanne M.
Varella-Garcia, Marileila
Moon, James
Mack, Philip C.
Blanke, Charles D.
Hirsch, Fred R.
Gandara, David R.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S795 - S795
[27] Randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC): Final results
Nokihara, H.
Ohe, Y.
Yamada, K.
Kawaishi, M.
Kato, T.
Yamamoto, N.
Sekine, I.
Kunitoh, H.
Saijo, N.
Tamura, T.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[28] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
Nakadate, Megumi
Yamazaki, Koichi
Konishi, Jun
Kinoshita, Ichiro
Sukoh, Noriaki
Harada, Masao
Akie, Kenji
Ogura, Shigeaki
Ishida, Takashi
Munakata, Mitsuru
Dosaka-Akita, Hirotoshi
Isobe, Hiroshi
Nishimura, Masaharu
ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
[29] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
Usui, K
Inoue, A
Ishimoto, O
Tanaka, M
Koinumaru, S
Matsubara, N
Kanbe, M
Gomi, K
Saijo, Y
Nukiwa, T
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
[30] PhaseI/II study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small lung cancer (NSCLC).
Ono, Y
Hino, M
Narato, R
Tanaka, Y
Kamizuru, R
Kitamura, K
Uehara, T
Kudoh, S
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 680S - 680S

← 1 2 3 4 5 →